Acrux Ltd. (ARUXF)
0.0033
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Acrux Cash from Operations (TTM) : 0.7159M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7159M |
| December 31, 2025 | -1.510M |
| June 30, 2025 | -3.471M |
| December 31, 2024 | -2.859M |
| June 30, 2024 | -2.824M |
| December 31, 2023 | 0.486M |
| June 30, 2023 | 0.4829M |
| December 31, 2022 | -4.163M |
| June 30, 2022 | -6.394M |
| December 31, 2021 | -8.643M |
| June 30, 2021 | -8.596M |
| December 31, 2020 | -6.365M |
| June 30, 2020 | -5.702M |
| December 31, 2019 | -5.273M |
| June 30, 2019 | -7.125M |
| December 31, 2018 | -7.271M |
| June 30, 2018 | -4.083M |
| December 31, 2017 | 1.019M |
| June 30, 2017 | 4.054M |
| December 31, 2016 | 7.886M |
| June 30, 2016 | 12.01M |
| December 31, 2015 | 11.75M |
| Date | Value |
|---|---|
| June 30, 2015 | 8.569M |
| December 31, 2014 | 29.10M |
| June 30, 2014 | 33.32M |
| December 31, 2013 | 11.23M |
| June 30, 2013 | 6.476M |
| December 31, 2012 | 4.480M |
| June 30, 2012 | -2.504M |
| December 31, 2011 | -22.96M |
| June 30, 2011 | 59.89M |
| December 31, 2010 | 124.81M |
| June 30, 2010 | 43.03M |
| December 31, 2009 | -4.781M |
| June 30, 2009 | -4.321M |
| December 31, 2008 | -3.897M |
| June 30, 2008 | -2.401M |
| December 31, 2007 | -4.505M |
| June 30, 2007 | -6.036M |
| December 31, 2006 | -6.490M |
| June 30, 2006 | -6.144M |
| December 31, 2005 | -4.815M |
| June 30, 2005 | -4.562M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Percheron Therapeutics Ltd. | -3.485M |
| Starpharma Holdings Ltd. | -2.255M |
| Neuren Pharmaceuticals Ltd. | 6.411M |
| Mayne Pharma Group Ltd. | 10.97M |
| Zelira Therapeutics Ltd. | -3.113M |